Faculty research
Econ expert weighs in: Will slimming down with GLP-1s widen health disparities?
The demand for GLP-1 weight-loss drugs is shifting consumer behavior and causing some manufacturers to do an about-face. Professor Mario Macis explores what might happen when results are promising but prices are high and coverage is limited.
October 23, 2025